Skip to main content

Day: January 7, 2026

Hypercharge Announces Hypercorp Energy Solutions to Orchestrate the Future of Energy Management

New energy platform initiative integrates battery storage, advanced energy management, and professional services to support electrification at scaleHypercorp Energy SolutionsHypercorp Energy Solutions expands Hypercharge into battery energy storage and intelligent energy management for commercial, fleet, and multi-family sites.VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading, smart electric vehicle (EV) charging solutions provider and network operator, is pleased to announce the launch of Hypercorp Energy Solutions (“Hypercorp”), a new energy services initiative that operates alongside Hypercharge Networks and expands the Company’s focus beyond EV charging into the approximately $40 billion USD global battery...

Continue reading

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 9:00 a.m. PT. A live webcast will be available on the Events and Presentations page in the Investors & Media section of Intellia’s website, www.intelliatx.com. A replay of the webcast will be available on Intellia’s website for approximately 30 days. About Intellia TherapeuticsIntellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on...

Continue reading

TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX — Light-Leverage Versions of TSPY and TDAQ Designed to Offer 30% More Exposure to Growth + Income

SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) — TappAlpha and Tuttle Capital Management, two innovators in ETF design, today jointly announced the launch of the T² Lift™ Series — a new line of ETFs seeking to offer light-leverage exposure to the daily income and growth strategies behind TSPY and TDAQ. The T² Lift™ Series aims to give investors 30% more exposure to the same daily growth and income strategies used in TSPY (S&P 500) and TDAQ (Nasdaq-100) — two of the fastest-growing ETFs in the market. These new funds use the same rules-based daily options approach, now with a light-leverage boost designed to increase both income potential and market participation. “Investors have been asking for a way to increase exposure to the TSPY and TDAQ strategy without reinventing the wheel,” said Si Katara, Founder and CEO at...

Continue reading

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference

CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Company representatives will also participate in investor meetings during the conference. A live webcast of the presentation, along with accompanying materials, will be available on the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay will be available within 48 hours following the presentation and will remain archived on the Company’s...

Continue reading

Capital Power extends its Arlington Valley tolling agreement to 2038 and increases its summer capacity by 35 MWs, enhancing reliability and long-term value

Extends Arlington Valley (Arlington) tolling agreement with the current counterparty by 7 years through 2038, increasing the remaining contract life to 13 years Adds 35 MW of incremental capacity to meet Arizona’s growing peak power demand Delivers a total estimated annual Adjusted EBITDA uplift of ~US$70 million by 2032EDMONTON, Alberta, Jan. 07, 2026 (GLOBE NEWSWIRE) — Capital Power (TSX: CPX) today announced the extension of its summer tolling agreement for the Arlington facility with the current counterparty, an investment-grade utility. The agreement extends the existing 2031 agreement through October 2038 providing 13 years of contracted revenue and positioning Capital Power for continued growth and value creation in the U.S. southwest. The 6-month contract structure enables the facility to capture increasing merchant...

Continue reading

Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence

ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials. This strategic acquisition expands Avance’s existing U.S. presence and marks a significant milestone in accelerating the company’s growth in oncology, the largest and fastest-growing therapeutic area in global R&D. Both organizations share a commitment to deliver high quality, innovative and efficient oncology clinical trials that accelerate the development of next-generation therapies to patients worldwide. LumaBridge will form the foundation of Avance’s global Oncology Center of Excellence. The LumaBridge team brings...

Continue reading

Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”), a digital asset treasury management company specializing in cryptocurrency custody and storage infrastructure, today announced the execution of a staking agreement with EdgeAI Foundation (the “Foundation”) to stake a portion of its EdgeAI token holdings. Under the terms of the agreement, DCX will stake over 100 million EdgeAI tokens to a Foundation-designated smart contract for a term of 12 months. The staking arrangement provides for a floating annualized yield of 3.5% to 8%, with rewards distributed in EdgeAI tokens. Upon maturity, staked tokens will automatically be unlocked and returned to DCX unless the parties agree in writing to renew the arrangement. The agreement enables...

Continue reading

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members of the Board of Directors holding preferred shares elected to convert their shares, along with all other preferred shareholders, at a shareholder-friendly 85% premium to the market price. Glucose Health, Inc. Board Member, Chris Jemapete stated: “Some of the preferred series carried dividends with quarterly cash payments to shareholders. In one of our first actions as new Board members, we concluded that cash on hand should be prioritized to finance the future growth of the Company and its national soluble fiber nutrition brands, rather than paying dividends to shareholders, ourselves included.” Mr. Jemapete further...

Continue reading

Kraig Biocraft Laboratories Takes Possession of Three Strategic Mulberry Fields Advancing Massive Spider Silk Production Ramp-Up

ANN ARBOR, Mich., Jan. 07, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it has taken possession of three critical mulberry fields for which it previously secured usage rights. The Company has now integrated this new feedstock capacity directly into the ramp-up of its current spider silk production. With these fields now dedicated solely to its operational use, Kraig Labs has implemented an aggressive production scale-up slated to dramatically advance spider silk production and prepare silk needed to fulfill outstanding materials requests. Mulberry leaf from these fields is now being incorporated into active silkworm rearing cycles, strengthening the Company’s operations...

Continue reading

Oroco Announces Bought Deal Financing Led by Canaccord Genuity

VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Oroco Resource Corp. (TSX-V: OCO, OTCQB: ORRCF) (the “Company” or “Oroco”) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (“Canaccord Genuity”), as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 39,474,000 units of the Company (the “Units”) at a price of C$0.38 per Unit (the “Offering Price”) for gross proceeds to the Company of approximately C$15.0 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to acquire...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.